Received Feb 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
my arm is sore; Redness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 12-FEB-2025, the patient received the 2nd dose of Shingrix. In FEB-2025, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: my arm is sore) and erythema (Verbatim: Redness). The outcome of the pain in arm and erythema were not resolved. It was unknown if the reporter considered the pain in arm and erythema to be related to Shingrix. It was unknown if the company considered the pain in arm and erythema to be related to Shingrix. Additional Information: GSK receipt date: 15-FEB-2025 This case was reported by a patient via interactive digital media. The reporter reported that he/she had received second dose of Shingrix vaccine on Wednesday (12th February 2025) and experienced arm sore and redness was worse on the day of reporting than day before reporting.